±ØºÝ’ÊMŒöŠJ±ÝÃÅid:mayumiel 1/23Íß°¼Þ ¤ ‚Î‚ç‰æ‘œ’u‚«ê œ05/18 06:49 ‚΂罨°æ¶ 42 views31 views29 viewsײÌÞÁ¬¯Ä@‚ç‚ñ‚¿‚á‚ñiranran_chj‘åŠw¶¤Žï–¡‹óŽè28 views2024.09.212025.05.02ײÌÞÁ¬¯Ä ‚µ‚Ì‚ñi-SHINON-j24Î28 views2024.10.022025.05.0226 viewsÅÂiNATINATU252525j‚³‚ñ‚ÌײÌÞÁ¬¯Äistripchatj‚ɂ‚¢‚Ä25 views2025.05.0725 views20 viewsMegu_Meloni‚ß‚®‚Ýj‚³‚ñ‚ÌײÌÞÁ¬¯Äistripchatj‚ɂ‚¢‚Ä17 views2025.05.09924 views790 views762 views732 views565 views518 views452 viewsײÌÞÁ¬¯Ä ‚è‚Ù‚¿‚á‚ñ(_RIHO_51)444 views ¤ ‚ ‚©‚ß‚µ‚Ü‚¦I œ05/18 06:48 ‚ ‚©‚ß‚µ‚³‚ñ 2025”N5ŒŽ16“ú10‘ã—«‚ɂ킢‚¹‚–¢‹—e‹^‚Å‚Z‹³—@‚ð‘ß•ß ¡t‚ÌbŽq‰€oêZ‚Ì–ì‹…•”ŒÚ–â – ‹ž“sV•·ÃÞ¼ÞÀÙ10‘ã—«‚ɂ킢‚¹‚–¢‹—e‹^‚Å‚Z‹³—@‚ð‘ß•ß ¡t‚ÌbŽq‰€oêZ‚Ì–ì‹…•”ŒÚ–â ‹ž“sV•·ÃÞ¼ÞÀÙ102025”N5ŒŽ15“úŒF–{Žs“à‚ÌÎÃÙ‚Å’ml—«‚ɂ킢‚¹‚‚Èsˆ× ¼‰YŽs‚Ì77ÎŒö–±ˆõ‚Ì’j‚ð‘ß•ßs’·èt – “úÃÚNEWS NNNŒF–{Žs“à‚ÌÎÃÙ‚Å’ml—«‚ɂ킢‚¹‚‚Èsˆ× ¼‰YŽs‚Ì77ÎŒö–±ˆõ‚Ì’j‚ð‘ß•ßs’·èt “úÃÚNEWS NNN102025”N5ŒŽ15“úy‘¬•ñz•Ê‚Ì—Ž™‚ɂ૓I–\s‹^‚¢¤Œ³_“¹m’·‚ð6‰ñ–Ú‘ß•ß ‚í‚¢‚¹‚Âsˆ×½Ï΂ŎB‰e‚© ”íŠQŽÒ5l‚É ç—t¥ŽsŒ´ – Yahoo!ư½y‘¬•ñz•Ê‚Ì—Ž™‚ɂ૓I–\s‹^‚¢¤Œ³_“¹m’·‚ð6‰ñ–Ú‘ß•ß ‚í‚¢‚¹‚Âsˆ×½Ï΂ŎB‰e‚© ”íŠQŽÒ5l‚É ç—t¥ŽsŒ´ Yahoo!ư½102025”N5ŒŽ15“ú—«‚ɂ킢‚¹‚ ¤ ‚͂ĂȱÝÃÅ - ±ØºÝ’ÊMŒöŠJ±ÝÃÅ œ05/18 04:35 ‰ª“c^‹| 2025/05/18 03:16:12 ‚ ‚©‚ß‚µ‚Ü‚¦I ‚ ‚©‚ß‚µ‚³‚ñ2025/05/18 01:35:01 ‚͂ĂȱÝÃÅ - ±ØºÝ’ÊMŒöŠJ±ÝÃÅ ‰ª“c^‹| ¤ ----MOMOSE-NET---- œ05/09 19:52 ‚à‚à‚¹‚½‚܂ݢ‚¹‚ñ‚¹‚¢£ MatrixinsClusters are colored according to identities in (B)May 8, 2025 No CommentsClusters are colored according to identities in (B). IBI37G5 shows FcRs-independent agonism and antitumor effect IBI37G5 synergizes with anti-PD1 antibody to control established murine tumors IBI37G5 exhibits best antitumor efficacy at doses near-saturating target receptors Determining the optimalin vivoefficac ¤ Japanese Movie Database œ05/07 19:51 2025-05-06 (Tue) 20:26:38 2043 - 20432025-05-06 (Tue) 20:26:19 2042 - 20422025-05-06 (Tue) 20:25:59 2041 - 20412025-05-06 (Tue) 20:25:42 2040 - 20402025-05-06 (Tue) 20:25:23 2039 - 2039 6.ŽŸ5> 0.‚͂ĂȱÝÃÅįÌß 8.‚±‚ÌÍß°¼Þ‚ð—F’B‚ÉЉî 9.‚±‚ÌÍß°¼Þ‚Ìæ“ª‚Ö ÍÙÌß /‚¨’m‚点 Û¸Þ²Ý –³—¿Õ°»Þ°“o˜^ ‚͂ĂÈįÌß (c) Hatena